Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery

S Waheed, Z Li, F Zhang, A Chiarini, U Armato… - Journal of …, 2022 - Springer
The rapid advancement of nanomedicine and nanoparticle (NP) materials presents novel
solutions potentially capable of revolutionizing health care by improving efficacy …

[HTML][HTML] Liposome-polymer complex for drug delivery system and vaccine stabilization

AK Umar, N Wathoni, JH Zothantluanga, S Das… - Heliyon, 2022 - cell.com
Liposomes have been used extensively as micro-and nanocarriers for hydrophobic or
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …

Malaria vaccines: progress to date

DI Stanisic, MF Good - BioDrugs, 2023 - Springer
Malaria is a mosquito-borne disease caused by protozoan parasites of the genus
Plasmodium. Despite significant declines in malaria-attributable morbidity and mortality over …

Current approaches to malaria vaccines

PE Duffy - Current opinion in microbiology, 2022 - Elsevier
Highlights•First malaria vaccine RTS, S induces anti-sporozoite antibodies to protect
children.•Whole-sporozoite vaccines induce T cells and antibodies and confer field …

In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives

Y Zeng, F Zou, N Xia, S Li - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction Vaccines are powerful tools for controlling microbial infections and preventing
epidemics. To enhance the immune response to antigens, effective subunit vaccines or …

First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly …

JN Hutter, PM Robben, C Lee, M Hamer, JE Moon… - Vaccine, 2022 - Elsevier
The global burden of malaria remains substantial. Circumsporozoite protein (CSP) has been
demonstrated to be an effective target antigen, however, improvements that offer more …

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

WC Huang, MT Mabrouk, L Zhou, M Baba… - Communications …, 2022 - nature.com
A vaccine targeting multiple stages of the Plasmodium falciparum parasite life cycle is
desirable. The sporozoite surface Circumsporozoite Protein (CSP) is the target of leading …

Protective antibody threshold of RTS, S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model

CJ Genito, K Brooks, A Smith, E Ryan, K Soto, Y Li… - npj Vaccines, 2023 - nature.com
Mouse models are useful for the early down-selection of malaria vaccine candidates. The
Walter Reed Army Institute of Research has optimized a transgenic Plasmodium berghei …

Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

MD Langowski, FA Khan, S Savransky, DR Brown… - npj Vaccines, 2022 - nature.com
Abstract The Circumsporozoite Protein (CSP) of Plasmodium falciparum contains an N-
terminal region, a conserved Region I (RI), a junctional region, 25–42 copies of major …

Advancements and challenges in developing malaria vaccines: Targeting multiple stages of the parasite life cycle

Rajneesh, R Tiwari, VK Singh, A Kumar… - ACS Infectious …, 2023 - ACS Publications
Malaria, caused by Plasmodium species, remains a major global health concern, causing
millions of deaths annually. While the introduction of the RTS, S vaccine has shown promise …